-
1دورية أكاديمية
المؤلفون: Prickett, TCR, Espiner, EA, Irving, M, Bacino, C, Phillips, JA, Savarirayan, R, Day, JRS, Fisheleva, E, Larimore, K, Chan, ML, Jeha, GS
العلاقة: pii: 10.1038/s41598-021-03593-1; Prickett, T. C. R., Espiner, E. A., Irving, M., Bacino, C., Phillips, J. A., Savarirayan, R., Day, J. R. S., Fisheleva, E., Larimore, K., Chan, M. L. & Jeha, G. S. (2021). Evidence of feedback regulation of C-type natriuretic peptide during Vosoritide therapy in Achondroplasia. SCIENTIFIC REPORTS, 11 (1), https://doi.org/10.1038/s41598-021-03593-1Test.; http://hdl.handle.net/11343/305460Test
-
2دورية أكاديمية
المؤلفون: Savarirayan, R, Tofts, L, Irving, M, Wilcox, WR, Bacino, CA, Hoover-Fong, J, Font, RU, Harmatz, P, Rutsch, F, Bober, MB, Polgreen, LE, Ginebreda, I, Mohnike, K, Charrow, J, Hoernschemeyer, D, Ozono, K, Alanay, Y, Arundel, P, Kotani, Y, Yasui, N, White, KK, Saal, HM, Leiva-Gea, A, Luna-Gonzalez, F, Mochizuki, H, Basel, D, Porco, DM, Jayaram, K, Fisheleva, E, Huntsman-Labed, A, Day, JRS
العلاقة: pii: S1098-3600(21)05439-3; Savarirayan, R., Tofts, L., Irving, M., Wilcox, W. R., Bacino, C. A., Hoover-Fong, J., Font, R. U., Harmatz, P., Rutsch, F., Bober, M. B., Polgreen, L. E., Ginebreda, I., Mohnike, K., Charrow, J., Hoernschemeyer, D., Ozono, K., Alanay, Y., Arundel, P., Kotani, Y. ,. Day, J. R. S. (2021). Safe and persistent growth-promoting effects of vosoritide in children with achondroplasia: 2-year results from an open-label, phase 3 extension study. GENETICS IN MEDICINE, 23 (12), pp.2443-2447. https://doi.org/10.1038/s41436-021-01287-7Test.; http://hdl.handle.net/11343/287664Test
-
3دورية أكاديمية
المؤلفون: Savarirayan, R, Irving, M, Maixner, W, Thompson, D, Offiah, AC, Connolly, DJA, Raghavan, A, Powell, J, Kronhardt, M, Jeha, G, Ghani, S, Fisheleva, E, Day, JRS
العلاقة: Savarirayan, R., Irving, M., Maixner, W., Thompson, D., Offiah, A. C., Connolly, D. J. A., Raghavan, A., Powell, J., Kronhardt, M., Jeha, G., Ghani, S., Fisheleva, E. & Day, J. R. S. (2021). Rationale, design, and methods of a randomized, controlled, open-label clinical trial with open-label extension to investigate the safety of vosoritide in infants, and young children with achondroplasia at risk of requiring cervicomedullary decompression surgery. SCIENCE PROGRESS, 104 (1), https://doi.org/10.1177/00368504211003782Test.; http://hdl.handle.net/11343/273983Test
-
4دورية أكاديمية
المؤلفون: Day JRS, Punjabi PP, Randi AM, Haskard DO, Landis RC, Taylor KM
المصدر: Circulation; 2004 Oct 26, Vol. 110 Issue 17, p2597-2600, 4p